• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Monday, March 8, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Potential New Drug Target for Lung Cancer

Bioengineer by Bioengineer
January 26, 2015
in Cancer
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A new study by University of Kentucky Markey Cancer Center researchers suggests that targeting a key enzyme and its associated metabolic programming may lead to novel drug development to treat lung cancer.

Cancer cells undergo metabolic alterations to meet the increased energy demands that support their excess growth and survival. The Krebs cycle in the mitochondria of cells is used to supply both energy and building materials for cell growth. Two mitochondrial enzymes – pyruvate carboxylase (PC) and glutaminase replenish carbon to the Krebs cycle.

Published in the Journal of Clinical Investigation, the study collected metabolic data directly from more than 120 human lung cancer patients. Researchers Teresa Fan, Andrew Lane, and Richard Higashi, now part of UK’s Center for Environmental and Systems Biochemistry (CESB), worked with other collaborators to measure the in situ activity of these two enzymes in patients with early stage lung cancer. When they infused the patients with a glucose tagged with stable heavy atoms immediately prior to surgical removal of tumor tissue, they found that PC was selectively activated – in other words, PC expression may play an important role in the development of lung cancer.

By using molecular genetic tools to reduce the amount of PC in human lung cancer cells, the team observed decreased cell growth, a compromised ability to form colonies in soft agar (a gelatinous material specifically used to grow bacteria and other cells), and a reduced rate of tumor growth in mice. The loss of PC also induced widespread changes in the central metabolism of the cell, suggesting a role for PC in early stage metabolic reprogramming.

“We now know much more about metabolic reprogramming of cancerous tissues in human patients, particularly that the activation of pyruvate carboxylase is important to lung cancer cell growth and survival,” said Fan, UK professor of toxicology and faculty member of the Markey Cancer Center and CESB at the University of Kentucky. “Ultimately, figuring out how to target PC may help researchers develop new, more effective therapeutic strategies to improve upon current lung cancer treatments, which are limited and harmful.”

The team’s work was funded by the National Cancer Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, and the National Institutes of Health (NIH)Common Fund. UK’s RC-SIRM is one of six NIH Common Fund-supported Regional Comprehensive Metabolomics Resource Centers. The overall mission of the Center is to enable cutting-edge approaches and to provide state-of-the art instrumentation for stable isotope-resolved metabolomics.

Unlike radioactive isotopes, stable isotopes do not decay, and they occur naturally in the body in low amounts. Enriching these isotopes with glucose or glutamine allows researchers to track the atoms through the metabolic transformation process, so researchers can backtrack to see what reactions have occurred and detect whether cancer cells have altered the metabolic pathway.

Story Source:

The above story is based on materials provided by University of Kentucky College of Medicine.

Share12Tweet7Share2ShareShareShare1

Related Posts

IMAGE

Oncotarget: High-fat ovariectomized mice susceptible to accelerated tumor growth

March 8, 2021
IMAGE

Oncotarget: Estrogen receptor α polymorphism is associated with dementia

March 8, 2021

Oncotarget: Sensitivity testing on ovarian cancer cells isolated from malignant ascites

March 8, 2021

The amazing promise of artificial intelligence in health care

March 8, 2021

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    Terahertz accelerates beyond 5G towards 6G

    702 shares
    Share 281 Tweet 176
  • People living with HIV face premature heart disease and barriers to care

    86 shares
    Share 34 Tweet 22
  • Global analysis suggests COVID-19 is seasonal

    39 shares
    Share 16 Tweet 10
  • HIV: an innovative therapeutic breakthrough to optimize the immune system

    36 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

cancerCell BiologyEcology/EnvironmentTechnology/Engineering/Computer ScienceBiologyMedicine/HealthChemistry/Physics/Materials SciencesClimate ChangeMaterialsGeneticsInfectious/Emerging DiseasesPublic Health

Recent Posts

  • Canadian innovators use video games to help children with neurodevelopment disabilities
  • Speeding treatment for urinary tract infections in children
  • New technique brings the study of molecular configuration into the microscopic domain
  • Rise of marine predators reshaped ocean life as dramatically as sudden mass extinctions
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In